Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453141 · ClinicalTrials.gov registry record · NA
Betamethasone Dosing Interval - 12 or 24 Hours?
A NA study, sponsored by The Cooper Health System.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT00453141 is a NA study that has completed, run by The Cooper Health System. The registered enrollment target is 200 participants.
The verdict
NCT00453141, a NA study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if there may be a benefit to the newborn if betamethasone is given 12 hours apart instead of 24 hours apart.
Interventions
- DRUG dosing of Betamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00453141
The ClinicalTrials.gov registry entry for NCT00453141 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which dosing of Betamethasone is the first listed.
NCT00453141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00453141 about?
NCT00453141 is a clinical study titled "Betamethasone Dosing Interval - 12 or 24 Hours?". The purpose of this study is to determine if there may be a benefit to the newborn if betamethasone is given 12 hours apart instead of 24 hours apart.
What is the current status of trial NCT00453141?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2006-04. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00453141?
The interventions under investigation include: dosing of Betamethasone (DRUG).
Who is sponsoring clinical trial NCT00453141?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.